Drugs / LSCD101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04773431 | Jan 2020 → Jan 2021 | limbal stem cell deficiency | CliPS Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSCD101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04773431 ↗ |
| Known as | Cultured Autologous Limbal Epithelial Cell Sheet | “LSCD101 (Cultured Autologous Limbal Epithelial Cell Sheet) is transplanted in the lesion.” NCT04773431 ↗ |
| Modality | Cell therapy | “Cultured Autologous Limbal Epithelial Cell Sheet” NCT04773431 ↗ |